National Academy of Medicine

Clinical Effectiveness Research

Methods innovation and practice-based approaches

Innovation Collaborative Brochure

Richard Platt, M.D., M.S. (Co-Chair)

Richard Platt, MD, MS (Co-Chair)

Richard Kuntz, MD, MSc (Co-Chair)

Richard Kuntz, MD, MSc (Co-Chair)

The constantly increasing diversity and sophistication of health care interventions hold great promise for gains in patient health, but also raise substantial challenges to the pace and nature of research about the effectiveness of treatments. Clinical research is straining to keep up with the rapid and iterative evolution of medical interventions and the innovation that occurs in clinical practice. It has become clear that, while trials are key especially to pre-market assessment of safety and efficacy, depending on trials is impractical — in both time and cost — for the information needed on effectiveness and efficiency.

Recent enhancements in the nation’s capacity for clinical effectiveness research (CER), and the characterization of the broad range of CER questions of national priority, underscore the need to accelerate the development and use of innovative approaches for learning about what works best for whom and under what circumstances. Such information is critical for clinical and policy decisions and requires more nimble and efficient approaches that take advantage of emerging statistical tools and techniques, research designs and analytic models that can be applied across broader population groups, and information developed as a natural byproduct of the care process. Accelerated initiative within the research community is essential for progress — particularly to improve the targeting, tailoring, sequencing of approaches to develop a totality of evidence. Efforts to enhance the use of genomic information, probability and other models that accelerate the timeliness and level of research insights gained, and the development of virtual intervention studies also offer increased prospects for transformative change in clinical outcomes research.

  • Participants

    Individual researchers with research innovation interests, capacity, and activities from public and private organizations, leading academic research institutions, insurers, health product manufacturing companies, and product assessment companies. The aim is for an inclusive Collaborative—without walls—and participation in individual projects is structured according to interest, need, and practicality.

    Representative Participants


    Association of American Medical Colleges
    Brigham and Women’s Hospital
    Bristol-Myers Squibb
    Cedars-Sinai Medical Center
    Center for Medical Technology Policy
    Duke Clinical Research Institute
    Harvard Medical School
    Harvard School of Public Health
    Institute for Clinical and Economic Review
    Institute for Clinical Research and Health
    Policy Studies, Tufts Medical Center
    Johnson & Johnson
    Kaiser Permanente
    Mayo Clinic
    Outcome Sciences Inc.,
    University of California, Davis
    University of California, Irvine
    University of California, Los Angeles
    University of Minnesota School of Public Health
    University of Pennsylvania School of Medicine
    University of Pennsylvania School of Nursing
    University of Pittsburgh
    Vanderbilt University Medical Center
    World Health Information Science Consultants

    Federal Agencies

    U.S. Department of Health & Human Services

    • Agency for Healthcare Research and Quality
    • Centers for Medicare & Medicaid Services
    • Food and Drug Administration
    • National Institutes of Health
    • Office of the Secretary

    U.S. Department of Veterans Affairs

  • Activities

    Projects completed, under way, or under consideration by CERIC include:

    • Field advancement mapping. Cooperative development of a White Paper exploring the major institutional, organizational, and regulatory challenges and opportunities for expediting clinical effectiveness research.
    • Engaging health system leadership in CER. A program of work that begins by engaging health system leadership on issues and opportunities to transform how evidence is generated and used to improve health and the value of delivered care as a fundamental part of their institutional processes, and provides a neutral forum to discuss and share insights from ongoing evidence application and development efforts.
    • Advancing the use of “small data” in continuous learning. Cooperative development of a working group to explore how a continuous learning system can generate knowledge and insights at the population level, while improving the precision of the application of results from rich, patient-generated data at the individual level.
    • Eliminating disparities. An exploration of how features of a continuously learning health system can best address and close the gaps for our most salient health and health care disparities, with particular focus on opportunities from innovation in clinical effectiveness research.
  • Upcoming Meetings

For more information, contact Mahnoor Ahmed, Research Associate, at